DEA

RSS Feed for this category

Chronicle AM: Ontario Goes With State-Owned Pot Shops, DEA Agent's Sordid Affair, More... (9/11/17)

Canada's most populous province is going with a state monopoly on legal marijuana sales, the CARERS Act is back, last week's surprise budget deal preserves protections for legal medical marijuana states for a few more months, and more.

Medical Marijuana

Congressional Budget Deal Preserves Medical Marijuana Protections -- For Now. The budget deal agreed to last week between President Trump and congressional leaders extends federal protections to state-legal medical marijuana programs through December 8. This provides an opportunity for House GOP leaders to rectify their decision last week not to allow a vote on the amendment that for the past four years has blocked the Justice Department from spending federal funds to go after medical marijuana in states where it is legal.

Bipartisan Group of Senators Reintroduce CARERS Act. Sens. Cory Booker (D-NJ), Al Franken (D-MN), Kirsten Gillibrand (D-NY), Lisa Murkowski (R-AK), and Rand Paul (R-KY) refiled the CARERS Act (Senate Bill 1764) last Wednesday. The bill aims to "extend the principle of federalism to State drug policy, provide access to medical marijuana, and enable research into the medicinal properties of marijuana."

Iowa Attorney General Cites Fed Fears to Block CBD from Out of State Dispensaries. The attorney general's office has advised the Department of Public Health not to implement a part of the state's CBD medical marijuana law that would have licensed two dispensaries from bordering states to supply CBD to Iowa patients. "It is possible that state's program may come under increased scrutiny from the federal government," a spokesman told the Des Moines Register, adding that the halt would remain "until the federal government provides further guidance regarding state medical marijuana programs."

Drug Policy

Florida Attorney General Pam Bondi Joins Trump's Drug Task Force. A Republican and Trump supporter, Bondi has been appointed to the Presidential Commission on Drug Addiction and the Opioid Crisis, her office announced last Friday. The other commission members are chairman and New Jersey Gov. Chris Christie (R), Massachusetts Gov. Charlie Baker (R), North Carolina Roy Cooper (D), former US Rep. Patrick Kennedy (D-MA), and Harvard professor Dr. Bertha Madras. The commission is supposed to issue a final report by October 1.

Heroin and Prescription Opioids

New York Congressman Files Bill to Broaden Medication Assisted Treatment. Rep. Paul Tonko (D-NY) has filed House Resolution 3692 to "amend the Controlled Substances Act to provide additional flexibility with respect to medication-assisted treatment for opioid use disorders."

Law Enforcement

DEA Agent's Scandalous Affair Unveiled. A Justice Department inspector general's report released last Thursday revealed one bit of juicy scandal: A DEA agent carried on a wild affair with a convicted drug criminal for five years, and let her listen to active wiretaps, roam the evidence room unattended, and had sex with her in his office and official vehicle. The whole thing unraveled when she got pregnant, he reacted unfavorably, and she ratted him out to superiors. The unnamed agent was originally only suspended for 45 days, but was eventually fired.

International

Ontario Will Only Allow Legal Pot Sales in Government Monopoly Shops. Canada's most populous province announced last Friday that it will open 150 standalone pot shops operated by the Liquor Control Board of Ontario (LCBO), as well as eventually allowing an online order service. Dispensaries that have sprouted up in the province are out of luck: "Illicit cannabis dispensaries are not and will not be legal retailers," the province explained in a news release. "The province will pursue a coordinated and proactive enforcement strategy, working with municipalities, local police services, the OPP and the federal government to help shut down these illegal operations."

Canadian Prime Minister Just Says No to Drug Decriminalization. Prime Minister Justin Trudeau has rejected calls from British Columbia public health and political figures to embrace drug decriminalization as part of a solution to the country's opioid crisis. "We are making headway on this and indeed the crisis continues and indeed spreads across the country but we are not looking at legalizing any other drugs than marijuana for the time being," Trudeau told a news conference in BC last Thursday.

German Poll Finds Solid Majority for Marijuana Legalization. A Mafo Market Research Institute poll has found signs of a rapid shift in support for freeing the weed in Germany. Polls going back to 2001 have had support hovering around 19%, but things began to change around 2014. That year, a poll had 30% supporting legalization. In November 2015, another poll had support at 42%. The new Mafo poll has support at 57.5%.

Trump BS Alert: The Border Wall Won't Stop Drug Smuggling [FEATURE]

This article was produced in collaboration with AlterNet and first appeared here.

The president doesn't let reality get in the way of rhetoric. (Creative Commons/Gage Skidmore)
President Trump sure loves his border wall. It was a staple of his campaign rhetoric, and despite Mexico's firm insistence that there is no way it's ever going to pay for it, Trump's desire for it is unabated. Now, he's threatening to shut down the government unless he can persuade the Congress to make American taxpayers pay for it.

Last week, Trump claimed that "building the wall will stop much of the drugs coming into the county." That claim is yet another example of what CNN contributor Fareed Zakaria pungently referred to as Trump's primary political product: bullshit.

Here's what Trump claimed during his joint press conference last Monday with Finnish President Sauli Niinisto:

"The wall will stop much of the drugs from pouring into this country and poisoning our youth. So we need the wall. It's imperative… The wall is needed from the standpoint of drug -- tremendous, the drug scourge, what's coming through the areas that we're talking about… So we will build the wall, and we will stop a lot of things, including the drug -- the drugs are pouring in at levels like nobody has ever seen. We'll be able to stop them once the wall is up."

And here's the reality: Trump's own DEA and outside experts agree that building a wall along the 1,700 mile land border with Mexico will have little impact on the drug trade. Not only do drugs from Latin America enter America by sea and air as well as across the Mexican border, but the vast majority of drugs crossing the land border do so not in unfenced desert expanses, but through official ports of entry.

Mexican drug trafficking organizations "transport the bulk of their drugs over the Southwest Border through ports of entry (POEs) using passenger vehicles or tractor trailers," the DEA said in its 2015 National Drug Threat Assessment. "The drugs are typically secreted in hidden compartments when transported in passenger vehicles or comingled with legitimate goods when transported in tractor trailers."

Here's how the DEA detailed trafficking methods for various drugs:

Methamphetamine: "Traffickers most commonly transport methamphetamine in tractor trailers and passenger vehicles with hidden compartments. In addition, traffickers send methamphetamine through various mail services or by couriers traveling via bus or commercial airline.

Heroin: "Most heroin smuggled across the border is transported in privately-owned vehicles, usually through California, as well as through south Texas."

Cocaine: "Tractor trailers and passenger vehicles are frequently used to transport multi-kilogram quantities of cocaine. Cocaine is hidden amongst legitimate cargo or secreted inside of intricate hidden compartments built within passenger vehicles."

Marijuana: "Large quantities of marijuana are smuggled through subterranean tunnels."

A May 2017 DEA intelligence report obtained by Foreign Policy echoed the 2015 assessment. It, too, found that drugs coming from Mexico went indeed cross the border, but they mainly do so concealed in vehicles using ports of entry -- not those unfenced expanses. That report also noted that drugs headed for the Northeast United States, especially from Colombia -- the world's leading cocaine producer, as well as source of opium and heroin second only to Mexico in the US market -- come more often by plane and boat.

Drug traffickers "generally route larger drug shipments destined for the Northeast through the Bahamas and/or South Florida by using a variety of maritime conveyance methods, to include speedboats, fishing vessels, sailboats, yachts, and containerized sea cargo," the report found. "In some cases, Dominican Republic-based traffickers will also transport cocaine into Haiti for subsequent shipment to the United States via the Bahamas and/or South Florida corridor using maritime and air transport."

That report did not address the border wall, but its examples of how and where drugs enter the country show that in many cases, building a wall wouldn't make a scintilla of difference: "According to DEA reporting, the majority of the heroin available in New Jersey originates in Colombia and is primarily smuggled into the United States by Colombian and Dominican groups via human couriers on commercial flights to the Newark International Airport," the report found.

The report concluded with recommendations for reducing the drug trade, but none of them were about building a border wall. Instead, targeting foreign drug trafficking networks within the US "would be an essential component to any broad strategy for resolving the current opioid crisis."

It's not just his own DEA that is giving the lie to Trump's bullshit. His own chief of staff, John Kelly contradicted the president's position at a congressional hearing in April. Illegal drugs from Mexico "mostly come through the ports of entry," he said. "We know they come in in relatively small amounts, 10, 15 kilos at a time in automobiles and those kinds of conveyances."

Drug trafficking experts agreed with Kelly and the DEA -- not Trump.

Brookings Institution senior fellow and long-time analyst of drug production and trafficking Vanda Felbab-Brown summed things up bluntly in an essay earlier this month: "A barrier in the form of a wall is increasingly irrelevant to the drug trade as it now practiced because most of the drugs smuggled into the US from Mexico no longer arrive on the backs of those who cross illegally."

"The wall won't stop the flow of drugs into the United States," she told Fact Check last week.

Other experts contacted by Fact Check concurred. University of Maryland criminal justice professor and founder of the RAND Drug Policy Research Center Peter Reuter pronounced himself skeptical that a wall would have any impact on the drug trade.

"The history is that smugglers eventually figure a workaround," he said. "There have been many promising interdiction interventions -- none of them have made more than a temporary dent."

And Middle Tennessee State University political science professor Stephen D. Morris, whose research has largely focused on Mexico, came up with two reasons the border wall would not stop drugs.

"First, as you say, most drug shipments come disguised as commerce and are crossing the border by truck or in cargo containers. Human mules, to my knowledge, bring in a small fraction," he said. "Second, smugglers adapt. Whether it is tunnels, submarines, mules, drones, etc., they are good at figuring out new ways to get drugs to those in the US who will buy them."

It is a shame that Donald Trump's ascendency has so coarsened and vulgarized our national political discourse. But his lies demand a forthright response. Bullshit is bullshit.

Chronicle AM: White House Seeks MA MedMJ Data, Ecstasy for PTSD Advances, More... (8/28/17)

The White House is sniffing around Massachusetts medical marijuana patient data, the FDA has granted breakthrough drug status for MDMA as a treatment of PTSD, the DEA warns of a looming tide of cocaine, the State Department's top anti-drug official calls it quits, and more.

Cocaine supplies and seizures are at record levels, the DEA says. (US CBP)
Medical Marijuana

White House Seeks Massachusetts Data On Medical Marijuana Users. The National Marijuana Initiative, part of the Trump administration's anti-drug task force, has asked the state Department of Public Health to provide data on the health conditions cited by medical marijuana users. The department has already provided data on patient by age and gender, but said it was considering whether to hand over additional data.

Tennessee Lawmakers to Study Whether to Legalize Medical Marijuana. Lt. Gov. Randy McNally (R) and House Speaker Beth Harwell (R-Nashville) announced in a letter last Friday that they are forming an ad hoc committee to study whether the state should legalize medical marijuana. The lawmakers said they would undertake a comprehensive review of the matter. The committee will consist of 10 legislators.

Ecstasy

FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Psychotherapy for PTSD. The Multidisciplinary Association for Psychedelic Studies (MAPS) announced last Friday that Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of posttraumatic stress disorder (PTSD). MAPS and the FDA have also reached agreement under the Special Protocol Assessment Process (SPA) for the design of two upcoming Phase 3 of MDMA-assisted psychotherapy for patients with severe PTSD. MDMA-assisted psychotherapy is a novel treatment package that combines psychotherapeutic techniques with three administrations of MDMA as a pharmacological adjunct. By granting Breakthrough Therapy Designation, the FDA has agreed that this treatment may have a meaningful advantage and greater compliance over available medications for PTSD.

Drug Policy

State Department's Top Anti-Drug Diplomat Joins Exodus, Resigns. William Brownfield, the US Assistant Secretary of State for International Narcotics and Law Enforcement Affairs ("drugs and thugs"), has announced he is quitting at the end of September. Foreign Policy had reported that Secretary of State Rex Tillerson was considering Brownfield for a position as top envoy to Latin America, but instead Brownfield is leaving. His departure is only the latest of top officials from Foggy Bottom, including Brownfield's wife, Kristie Kenney, one of the department's senior foreign service officers, a few months back. Also resigning Friday, was Tracey Ann Jacobsen, the acting director of the Bureau of International Organization Affairs. Earlier in the week, Foreign Policy reported that the department's top official for European affairs, John Heffern, was forced out of his job, adding to "concerns of a growing wave of resignations by foreign policy professionals who are either being pushed out or resigning over frustration with an administration that has downgraded the importance of Washington's diplomatic corps."

Search and Seizure

Indiana Appeals Court Rules Genital Search for Blunt too Intrusive. The state Court of Appeals ruled last week that a police officer's search that included touching a woman's genitals was unconstitutional. Taccasia Porter had been convicted of marijuana possession, but appealed her conviction, arguing that the marijuana found in her underwear shouldn't have been admitted as evidence because it was the fruit of an unlawful search. The appeals court agreed, saying that while an initial search was lawful, the hands-down-the-pants search was not. "While the initial pat-down search was permissible, we find that the subsequent search ran afoul of both the federal and state constitutions," wrote appellate Judge John G. Baker. "All of this took place in a public area on the side of a road, with no evidence that any precautions were taken to protect Porter's privacy from pedestrian or vehicular passers-by or the two men on the scene," the opinion said. No word yet on whether prosecutors will appeal.

International

DEA Report Says Colombia Cocaine Expansion Fueling Rise in Use and Supply in the US. An August DEA Intelligence Brief notes that US cocaine supplies are at the highest levels since at least 2007 and the usage has jumped to the highest levels since 2009. The report also says that cocaine production and US border seizures "have reached the highest levels ever observed. The DEA argued that cocaine supply and us in the US will continue to rise barring a change in US drug habits, cartel behavior, or "a significant shift in the Government of Colombia's policies."

Trudeau Government Not Decriminalizing More Drugs Than Marijuana. Responding to calls from public health and political figures in British Columbia to decriminalize drugs in a bid to combat the opioid overdose epidemic, federal Health Minister Jane Philpott says no way. "Our government is currently working on the legalization, strict regulation, and restriction of access to cannabis, in order to keep it out of the hands of youth, and profits out of the hands of criminals," she said in a statement last week. "We are not looking to decriminalize or legalize other illicit substances at this time."

Mass March for Philippine Teen Drug War Victim.More than a thousand people joined the funeral procession last Saturday for Kian Delos Santos, 17, who was gunned down by Philippines police days earlier as part of their bloody anti-drug campaign. His killing has galvanized opposition to the year-long campaign undertaken by President Rodrigo Duterte upon his inauguration last year, which has resulted in thousands of deaths and increasing attention to charges that police are systematically executing suspected drug users and dealers.

Sessions/Trump Pull Off an Amazing Feat -- Making the DEA Look Reasonable [FEATURE]

This article was produced in collaboration with AlterNet and first appeared here.

The Drug Enforcement Administration (DEA) has never been known as a forward-thinking place when it comes to drug and crime policy, but these days, the hide-bound drug fighting agency is coming off as much more reasonable on drugs than its bosses, President Trump and Attorney General Sessions.

DEA doing its thing. (Creative Commons/Wikimedia)
And as is the case with everyone from Republican elected officials to top corporate executives, the Trump administration's bad case of crazy is forcing even the DEA to distance itself from some of Trump's more ill-thought and insidious mouthings.

No, the DEA hasn't gone soft. It's still out there doing its best to enforce federal drug prohibition, and just last year it was old school enough to refuse to move pot out of Schedule I. But several recent incidents show a DEA behaving in a more responsible manner than the president or his attorney general:

1. The DEA has been accepting applications from scientists to grow marijuana for research purposes, only to be blocked by the Sessions Justice Department.

For years, researchers have complained that a government monopoly on marijuana grown for research purposes has both stifled useful research and illustrated the DEA's role in hindering science. Late in the Obama administration, though, the agency relented, saying it would take proposals from researchers to grow their own crops.

But The Washington Post reported last week that DEA had received 25 research proposals since it began accepting applications a year ago, but needed DOJ's approval to move forward. That approval has not been forthcoming, much like DOJ when queried about it by the Post. DOJ may not have had anything to say, but some insiders did.

"They're sitting on it. They just will not act on these things," said one unnamed source described by the Post as a "law enforcement official familiar with the matter."

Another source described as a "senior DEA official" said that as a result, "the Justice Department has effectively shut down this program to increase research registrations."

2. The DEA head feels compelled to repudiate Trump's remarks about roughing up suspects.

The Wall Street Journal obtained an email from acting DEA Administrator Chuck Rosenberg to staff members written after President Trump told police officers in Long Island month that they needn't be too gentle with suspects. Rosenberg rejected the president's remarks.

Saying he was writing "because we have an obligation to speak out when something is wrong," Rosenberg said bluntly that Trump had "condoned police misconduct."

Instead of heeding the president, Rosenberg said, DEA agents must "always act honorably" by maintaining "the very highest standards" in the treatment of suspects.

It is a strange state of affairs when an agency many people consider to be the very embodiment of heavy-handed policing has to tell its employees to ignore the president of the United States because he's being too thuggish.

3. The DEA has to fend off the Trump/Sessions obsession with MS-13.

Trump loves to fulminate against MS-13, the vicious gang whose roots lie in the Salvadoran diaspora during the US-backed civil war of the 1980s, and to use them to conflate the issues of immigration, crime, and drugs. His loyal attorney general has declared war on them. Both insist that breaking MS-13 will be a victory in the war on drugs and are pressuring the DEA to specifically target them.

But, the Post reported, Rosenberg and other DEA officials have told DOJ that the gang "is not one of the biggest players when it comes to distributing and selling narcotics."

In the DEA view, Mexican cartels are the big problem and MS-13 is simply one of many gangs the cartels use to peddle their wares. DEA administrators have told their underlings to focus on whatever is the biggest threat in their area -- not MS-13 -- because "in many parts of the country, MS-13 simply does not pose a major criminal or drug-dealing threat compared with other groups," according to unnamed DEA officials.

"The officials spoke on the condition of anonymity because they could face professional consequences for candidly describing the internal disputes," the Post noted.

The president and the attorney general are seeking to distort what the DEA sees as its key drug enforcement priorities so Trump can score some cheap demagogic political points, and the DEA is unhappy enough to leak to the press. We are indeed in a strange place.

Chronicle AM: Groups Oppose New Fed Bill, Still no DEA Research Grow Licenses, More... (7/5/17)

Drug reformers and others are trying to stop a bill that would give Attorney General Sessions new powers to criminalize new drugs and craft new penalties, after a year the DEA still hasn't issued any new marijuana research grow licenses, and more.

Civil rights, human rights, criminal justice, and drug policy reform groups are mobilizing to stop a new drug war bill.
Marijuana Policy

DEA Still Hasn't Issued Any New Marijuana Grower Licenses. Almost a year after the DEA announced it would allow more organizations to produce marijuana for research purposes, it has yet to do so. Although DEA has received 25 applications for research grows, it says it is still processing them and has no estimate for when any applications may be granted. There is increasing demand for research marijuana, as well as for more potent, more diverse, and higher quality marijuana than is being produced by the University of Mississippi under a NIDA monopoly it has enjoyed since 1968.

Massachusetts Lawmakers Get Back to Work on Crafting Legalization Implementation. The legislature missed a self-imposed Friday deadline for reaching agreement on competing legalization implementation bills in the House and Senate and the marijuana conference committee was set to meet today to try to seek agreement. Two big issues of dispute are tax rates and whether localities can ban pot businesses without a popular vote.

Industrial Hemp

West Virginia Joins the Ranks of Legal Hemp States. As of Tuesday, state residents can apply to the agriculture commissioner for a license to grow hemp for commercial purposes. Some growers grew hemp crops last year, but those were licensed research grows. Now, those growers can be licensed as commercial growers, too.

Drug Policy

Dozens of Reform Groups Send Letter to Congress Opposing New Drug War Bill. More than 60 civil rights, human rights, faith, criminal justice, and drug policy reform organization have sent a letter to the House Judiciary Committee opposing House Resolution 2851, the Stop the Importation and Trafficking of Synthetic Analogues Act of 2017. The measure is part of Attorney General Sessions' effort to reenergize the war on drugs and would give him sweeping new powers to schedule new drugs and set corresponding penalties, including new mandatory minimums. Similar legislation by Sens. Grassley and Feinstein has been filed in the Senate.

Chronicle AM: Mexico Legalizes MedMJ, China Bans More Synthetic Opioids, More... (6/20/17)

New Jersey pols look to legalize pot next year, Vermont pols look to legalize it this week, China bans more synthetic opioids, Mexico officially embraces medical marijuana, and more.

Medical marijuana is now officially legal in Mexico, but rules and regulations will take some time.
Marijuana Policy

New Jersey Legalization Bill Gets Hearing. The Senate Judiciary Committee held a hearing on a legalization measure, Senate Bill 3195, on Monday. The testimony was largely favorable, including from a former state Republican Committee head, the head of a doctors' organization favoring legalization, and from a long-time municipal prosecutor. "I believe by legalizing and regulating it and discouraging, officially as official government policy, like we do with tobacco and alcohol, we will be far better off than the status quo," prosecutor J.H. Barr told the committee. No vote was taken. The bill is strongly opposed by Gov. Chris Christie (R), but he'll be gone in January.

Vermont Legislators Will Try to Get Weed Legalized in Special Session This Week. Gov. Phil Scott (R) vetoed the legalization bill in May, saying he had public safety concerns. Supporters of legalization have come back with a bill that now has stiffer penalties for drugged driving, smoking pot in cars with kids, providing pot to kids, and selling pot in school zones -- all in a bid to win the governor's support. The bill does not include "impairment testing mechanism" requested by Scott, largely because there are no marijuana breathalyzers on the market. Scott has declined to comment on the revised bill. The special session begins Wednesday.

Harm Reduction

Boston Ponders Supervised Injection Sites. With six people a day dying of opioid overdoses in the city so far this year, the city council has set a hearing next Monday to explore the potential impact of supervised injection sites. The move comes after the Massachusetts Medical Society urged state officials to open at least two of the facilities.

International

China Bans Synthetic Opioids Linked to US Overdose Deaths. China announced on Monday that it is banning the ultra-potent synthetic opioid U-47700 and three others. The DEA says China is the chief source of synthetic opioids, including fentanyl and carfentanil, which China has already banned. U-47700, MT-45, PMMA, and 4,4-DMAR will be added to the country's list of controlled substances as of July 1, said Deng Ming, deputy director of the National Narcotics Control Commission.

Mexico Legalizes Medical Marijuana. President Enrique Pena Nieto issued a decree on Monday officially legalizing medical marijuana in the country. Legislation authorizing medical marijuana sailed through the Senate in December and passed the lower house on a 347-7 vote in April. Now, the Ministry of Health will be tasked with drafting and implementing rules and regulations.

Chronicle AM: DEA Lied About Honduras Incident, Not Guilty Verdict in SD MJ Case, More... (5/25/17)

A joint report from the Justice and State inspector generals' finds that the DEA lied and covered up the facts in a 2012 Honduran raid that left four innocent civilians dead, Peruvian security forces prepare to enter forbidden territory in the country's coca heartland, the South Dakota attorney general's ploy to win political advantage by prosecuting a pot consultant fails, and more.

Authorities in Honduras have discovered their first domestic coca plantation. (deamuseum.org)
Marijuana Policy

Maine Legislature Passes Bill to Fund the Implementation of the Marijuana Legalization Initiative and Change the Agency That Will Regulate Marijuana for Adult Use. The Senate on Thursday passed Legislative Document 243 unanimously "under the hammer," without debate or a roll call vote, sending it to Gov. Paul LePage (R) for final approval. The House passed it "under the hammer" on Wednesday. The bill would transfer the authority to oversee adult-use marijuana from the Department of Agriculture, Conservation and Forestry to the Bureau of Alcoholic Beverages and Lottery Operations within the Department of Administrative and Financial Services (DAFS). The Bureau would be responsible for licensing adult-use marijuana businesses and creating and enforcing regulations. LD 243 also allocates $200,000 to the Joint Select Committee on Marijuana Legalization Implementation and $1.4 million to DAFS to implement Question 1.

South Dakota Attorney General Foiled in Bid to Prosecute Pot Consultant for Personal Political Advantage. A jury in Flandreau acquitted a marijuana business consultant of conspiracy to possess and marijuana possession Wednesday. Eric Hagen, president of Colorado-based Monarch America, had contracted with the Flandreau Sioux tribe to assist it in developing a marijuana grow operation and resort, a plan that was abandoned by the tribe in the face of mixed signals from the federal government and staunch opposition from state officials. Led by Attorney General Marty Jackley (R), who is eying the state's governor's office, the state nine-months later charged Hagen and a business partner, even though they never possessed or controlled any marijuana. It took a juror just two hours to find Hagen not guilty. Hagen immediately accused Jackley of ruining his company through a politically motivated prosecution. "He tanked our company by spreading lies and rumors," Hagen said. "It was 100 percent politically motivated. This was simply a media ploy for Jackley because he's running for governor in 2018."

International

Peruvian Forces Set to Enter Key Coca Cultivation Area. Security forces are preparing to enter the lawless Apurimac, Ene, and Mantaro River valleys (VRAEM) coca growing areas for the first time as part of a plan to eradicate half the country's coca supply by 20121. The area, where an estimated 125,000-150,000 acres of coca is grown is remote, on the far side of the Andes, and the trade there is protected by armed rebel groups and drug trafficking organization. "It has to be done slowly, but it has to be done," Peru's drug czar Carmen Masias told a news conference.

Hondurans Bust First Coca Plantation. For years, Honduras has been a key transshipment point for cocaine headed from South America toward North American markets, but now Honduran authorities report finding their first domestic coca growing operation. They busted the field containing an estimated 7,000 plants last month in the mountainous region of Esquipulas del Norte. "We have confirmed through toxicological exams that we're dealing with coca plants. This is the first time we've confiscated a coca plantation in Honduras," prosecutor Carlos Morazan said. "At the site, we found a laboratory with tools and precursor chemicals for making coca paste and for processing the drug up to its final power form," Morazan added.

DOJ Report Says DEA Lied About Fatal Honduran Drug Raid. In 2012, a botched drug raid in Honduras led to the shooting deaths of four civilians, including a teenage boy, as they floated along a river. Now, a report from the Justice Department's Office of the Inspector General finds that the DEA lied when it claimed the victims were cocaine traffickers who had shot first and that DEA agents were only present as advisors. The report says the DEA failed to properly investigate, blocked attempts to find the truth, and stuck with an inaccurate version of events despite the efforts of Congress and the Justice Department to get to the bottom of it.

Chronicle AM: DEA Wants Prosecutor Corps, ME Gov Wants ODers to Pay for Naloxone, More... (5/4/17)

The DEA proposes its own corps of prosecutors to go after opioids, Maine's governor wants to force repeat overdosers to pay for the naloxone they use, and more.

Medical Marijuana

Colorado Legislature Approves Adding PTSD as Qualifying Condition. A bill to "Allow Medical Marijuana Use for Stress Disorders," Senate Bill 17, was sent to the governor's desk on Monday after the Senate last week approved a final concurrence vote to amendments accepted in the House. Gov. John Hickenlooper (D) is expected to sign it.

New York Assembly Approves PTSD as Qualifying Condition. The Assembly voted overwhelmingly on Tuesday to approve Assembly Bill 7006, sponsored by Health Committee Chairman Dick Gottfried (D-Manhattan), which would add PTSD to the state's list of qualifying conditions for medical marijuana. The bill now heads to the Senate.

Harm Reduction

Maine Governor Wants Repeat Overdosers to Pay for Naloxone Used to Revive Them. Gov. Paul LePage (R) has submitted a bill, Legislative Document 1558, that would require Maine communities to recover the cost of naloxone from repeat users and fine them $1,000 per incident if they don't go after the money. But doctors and advocates said the bill would make it harder to stop the state's wave of drug overdoses. Le Page is no friend of naloxone, saying it "does not truly save lives; it merely extends them until the next overdose." He has twice vetoed naloxone bills, only to see them overridden both times.

Law Enforcement

DEA Wants Own Prosecutor Corps to Go After Opioids. In a little-noticed proposal published in the Federal Register in March, the DEA said it wants to hire as many as 20 prosecutors to help it enhance its resources and target large offenders. The new prosecutor corps "would be permitted to represent the United States in criminal and civil proceedings before the courts and apply for various legal orders." Funding for the program would come from drug manufacturers regulated by the DEA. If approved, the move would mark the first time the DEA had its own dedicated prosecutors to go after drug offenses. But critics say the plan "exceeds DEA's authority under federal law" because it would require funding from the drug diversion registration program. "In this notice, the DEA effectively proposes a power grab and is trying to end-run the congressional appropriations process," said Michael Collins, deputy director at the Drug Policy Alliance.

Trump Drug Czar Nominee: Tough on Colombian Peasants and US Marijuana Users

President Trump will name Pennsylvania Congressman Tom Marino (R) to head the Office of National Drug Control Policy (ONDCP -- the drug czar's office), CBS News reported Tuesday. The White House gave no official comment, but sources told CBS that an official announcement would come soon.

Reported drug czar nominee Rep. Tom Marino (R-PA) (marino.house.gov)
Marino's legacy of legislative achievements around drug policy offers little comfort to reformers looking for signs that the "law and order" theme of the Trump administration may not be as bad as it sounds. Marino is a former prosecutor now in his third term in the House. His 2016 Transnational Drug Trafficking Act expands the ability of US prosecutors to use extraterritoriality to go after international drug traffickers, but while the law is touted as aiming at "kingpins," but observers south of the border have argued that the law "targets people on the lowest rungs of the trafficking ladder, i.e. Colombia's coca farmers." Marino has also been a reliable vote in opposition to marijuana reform in Congress.

Marino's rural congressional district has seen rising concern about heroin and opioids, and he serves on the House bipartisan committee combating the opioid epidemic. A bill he was an author and key supporter of in that area may suggest a more complex picture -- the 2016 Ensuring Patient Access and Effective Drug Enforcement Act, which supporters characterized as balancing the needs of patients, the pharmaceutical industry, and law enforcement, but which critics describe as a means of undercutting the DEA's ability to hold pharmaceutical drug distributors accountable for the diversion of large amounts of opioid pain relievers.

The ability of pain patients to have access to the drugs that can help them is a continuing -- and under-covered -- issue in the debate around prescription opioids. So is the ability of physicians to appropriately prescribe them within running afoul of regulatory authorities or even drug enforcement authorities. If Marino's bill reflects a concern with such issues, or a more general willingness to treat DEA pronouncements on such matters with skepticism, that could be useful. Conversely, however, the nation is also in the midst of a much more well-covered increase in the misuse of opioids. ONDCP has a role to play in promoting public health measures that can reduce overdoses and the risk of addiction. If Marino is too deferential to the preferences of big pharma lobbyists, while otherwise hooked on hard-line drug war approaches, opportunities to advance positive approaches for reducing the risks that go with opioids may be squandered.

In the fight over the 2016 Act, Marino, as chairman of the House Judiciary Committee on Regulatory Reform, clashed repeatedly with DEA Office of Diversion Control head Joseph Rannazzisi. In a 2014 conference call with congressional staffers, Rannazzisi warned that the bill, backed by a pharmaceutical industry lobbying campaign, would protect corporations engaged in criminal activity.

"[If t]his bill passes the way it's written we won't be able to get immediate suspension orders, we won't be able to stop the hemorrhaging of these drugs out of these bad pharmacies and these bad corporations," Rannazzisi recalled telling them. "What you're doing is filing a bill that will protect defendants in our cases."

Rannazzisi's opposition infuriated Marino, who ripped into the veteran DEA official's boss, then-DEA Administrator Michele Leonhart at a congressional hearing later that year.

"It is my understanding that Joe Rannazzisi, a senior DEA official, has publicly accused we sponsors of the bill of, quote, 'supporting criminals,' unquote" Marino said. "This offends me immensely."

A week later, Marino and Rep. Marsha Blackburn (R-TN) demanded that the Justice Department Office of the Inspector General investigate Rannazzis for "intimidating" members of Congress. Rannazzissi was replaced and retired in October 2015.

Marino's record is good enough for anti-marijuana crusader and former ONDCP advisor Kevin Sabet of Smart Approaches to Marijuana (Project SAM). "My understanding is that Tom has a deep understanding of the issue and is excited to get started," he enthused to CBS News.

But it's not good enough for anyone interested in a truly progressive approach to drug policy.

Chronicle AM: DOJ Reviewing MJ Policy, DEA Subpoenaed Over Snitch Program, More... (4/6/17)

A Justice Department review of marijuana policy is underway, congressional overseers subpoena the DEA over its snitch program, California's governor moves to reconicle the state's legal and medical marijuana programs, and more.

The DEA is in the hot seat with congressional investigators over its confidential informant program.
Marijuana Policy

DOJ Task Force is Reviewing Marijuana Policy. Attorney General Sessions issued a memo Wednesday saying that a task force on crime and public safety is reviewing federal marijuana policy and is charged with making initial recommendations by July 27. The task is reviewing ways to reduce violent crime and illegal immigration and is reviewing marijuana policy under that rubric.

California Governor Proposes Means of Melding Legal and Medical Marijuana Systems. Gov. Jerry Brown (D) on Tuesday released proposed legislation aimed at uniting the state's legal and medical marijuana regulatory systems. The draft language generally favors the less restrictive language of Prop 64, the state's successful marijuana legalization initiative. The Drug Policy Alliance, the California Cannabis Industry Association, the UFCW Western States Council, and the California Cannabis Manufacturers Association are all backing the draft language.

Alaska Regulators Punt (Again) on Onsite Consumption. The Marijuana Control Board was supposed to take up the thorny issue of permitting onsite consumption of marijuana Wednesday, but instead the board spent its meeting going through a backlog of license applications for production facilities and pot shops. "They really wanted to focus on approved applications at this meeting so people could get started with their businesses as we move into summer," said Erika McConnell, director of the Alcohol and Marijuana Control Board. "On site consumption was kind of the big time consuming issue that they pushed until the end and then we ran out of time." Onsite consumption decisions will now be pushed back until at least the May 15 meeting, she said.

Connecticut Legalization Bill Dead -- At Least for Now. A bill that would legalize marijuana, Senate Bill 11, appears dead in the water after it failed to make the agenda for a Friday meeting of the Senate Judiciary Committee. Reports are the bill, sponsored by Senate President Martin Looney (D-New Haven), was pulled because it didn't have enough votes to pass the committee. Legalization is not quite dead yet, though: The Looney bill or one of several other legalization proposals could still be attached as an amendment to another bill.

Virginia Commission to Study Decriminalization. The State Crime Commission decided on Wednesday that it will study marijuana decriminalization. The decision was made by the commission's executive committee.

Medical Marijuana

North Carolina Medical Marijuana Bill Filed. State Sens. Teresa Van Duyn (D) and Valerie Jean Fousher (D) filed Senate Bill 648 on Tuesday. Under the bill, patients could possess up to 24 ounces of marijuana and grow up to 250 square feet of their own medicine. The bill would also establish a system of licensed cultivation centers and dispensaries. It has been referred to the Committee on Rules and Operations.

Hemp

West Virginia Legislature Approves Industrial Hemp Bill. The Senate voted unanimously Wednesday to approve House Bill 2453, which would allow for the licensing of qualified producers and state institutions to grow hemp for industrial purposes. The bill passed the House last month and now heads to the desk of Gov. Jim Justice (D).

Asset Forfeiture

Arizona Asset Forfeiture Reform Bill Awaits Governor's Signature. Gov. Doug Ducey (R) is in a tight spot, caught between the wishes of legislators, who approved the asset forfeiture reform measure House Bill 2477, and county prosecutors, who are urging him to veto it. The measure would change Arizona's civil asset forfeiture laws to require prosecutors to prove property was involved in a crime by "clear and convicting" evidence, a step above the current standard. Gov. Ducey has said he thinks this is an area of law that needs reform, but hasn't said whether he would sign the bill into law.

Law Enforcement

DEA Gets Hit With Congressional Subpoenas Over Its Informant Program. Rep. Jason Chaffetz (R-UT), head of the House Oversight Committee, has subpoenaed the DEA for documents related to its confidential informant program. Congress members have been seeking copies of the guidelines since last year, when a Justice Department report detailed how DEA spent more than $200 million on informants with little oversight, but DEA has only allowed members to view the guidelines on-site. "Congress has a right to have this material," Chaffetz said, during an Oversight Committee hearing that he chaired on Tuesday morning. "It is unbelievable to me that you think we shouldn't have a copy of it," he told Deputy DEA Administrator Robert Patterson. Chaffetz then went next door to the House Judiciary Committee, where DEA Administrator Chuck Rosenberg was testifying, and issued a subpoena. "We are issuing a subpoena, and so I see no choice," he then told DEA chief Rosenberg. "The Department of Justice just doesn't get to hide things from the United States Congress," Chaffetz said, adding that there is evidence of "massive problems" in the program.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School